Industry overview
What is shaping pharmaceutical
Pharmaceutical and medical-device companies need evidence from doctors, pharmacists and patients, gathered with verified respondents, strict confidentiality and careful questionnaire design.
- Prescribing behaviour is shaped by evidence, experience and access
- Pharmacies influence brand substitution and adherence
- Patient journeys reveal unmet needs between visits
Client background
A pharmaceutical company, working in Pan-India. Client identity is withheld to protect confidentiality.
- Organisation
- A pharmaceutical company
- Sector
- Pharmaceutical
- Team engaged
- Market Research
- Services
- Healthcare panel, Quantitative research, Data analytics & dashboards
Client challenge
The company launched several brands in competitive therapy areas and needed to monitor awareness, prescribing intent and perception over time.
Research objectives
- Deliver on the brief: tracking brand perception among general physicians.
- Understand the views, needs and behaviour of physicians.
- Produce results that can be compared across groups and locations.
- Set up a repeatable measure the client can track over time.
Target audience
The work focused on 400 physicians.
- physicians400
Audiences we typically reach in pharmaceutical
Physicians and specialistsPharmacists and chemistsNurses and allied HCPsPatients and caregiversHospital procurement teams
Geographic coverage
Coverage: Pan-India. Market: India.
- India
Research methodology
A structured quantitative design, so results could be compared across groups, locations and time.
- 1Brief
- 2Quarterly HCP tracker
- 3Dashboard
- 4Insight
We ran a quarterly tracker with consistent questions and sample, with results on a dashboard by region and specialty.
Healthcare panelQuantitative researchData analytics & dashboards
Sampling strategy
- physicians
- 400
- Healthcare professionals and patients were screened on specialty, setting or condition, and professionals were verified before taking part.
- Online respondents were drawn from verified panel members who matched the screening criteria, with quotas on key profile attributes.
Data collection
- The online survey was mobile-friendly and offered in respondents' languages.
Data quality & validation
- Digital fingerprinting and duplicate checks
- Attention, speed and straight-lining checks
- Review of open-ended answers
- Verification of healthcare professionals
- Logic and range checks on the final data
- Work carried out under our ISO 20252 quality procedures
Data analysis
- Cross-tabulation by key groups and locations
- Significance testing on the differences that mattered
- Interactive dashboard for ongoing tracking
Key findings
- The tracker showed which brands gained ground after education programmes, and where perceptions lagged.
Consistency across waves made changes meaningful.
Recommendations
- Build on the core insight: consistency across waves made changes meaningful.
- Share the findings with the teams closest to customers so they can act quickly.
Business impact
- Marketing adjusted activity based on quarterly results.
Impact is described qualitatively.
Deliverables & next steps
- Insight report and management presentation
- Cleaned data file and data tables
- Interactive dashboard
- Continue the routine and review results every period.
- A natural follow-on question: how do doctors choose between therapies?
Client identity is withheld to protect confidentiality.